Sponsored Content
|Articles|March 19, 2020
Oncology Product Manufacturing in a Nondedicated Facility
Author(s)Baxter BioPharma Solutions
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
3
FDA Updates Master Protocol: What Developers Need to Know
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5